Patanjali Foods Ltd Q1 FY27 Earnings Call: PAT Surges 84% YoY, Guides Rs 2,500 Cr EBITDA Target
Cofacto Research
Published August 17, 2026
5 min read
Patanjali Foods Ltd held its Q1 FY27 earnings call on August 14, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
Broad-based revenue growth drives sharp profit expansion
- Revenue from operations Rs.11,337 Cr — up 29% YoY in Q1 FY 2026-2027, led by record edible oils and plantation revenue alongside strong FMCG performance.
- Operating EBITDA Rs.543 Cr (margin 4.80%) and PBT Rs.453 Cr (margin 4.0%) in Q1 FY 2026-2027, reflecting operating leverage across segments.
- Profit after tax grew 84% YoY in Q1 FY 2026-2027, the standout headline earnings number from the quarter.
- FMCG segment revenue Rs.2,938 Cr (EBITDA Rs.190 Cr, margin 6.45%) in Q1 FY 2026-2027, with biscuits and textured soy delivering particularly strong margin expansion.
- Commodity price inflation, delayed monsoon, Red Sea conflict, and Middle East tensions weighed on ghee exports and pushed up packaging, freight, and logistics costs during the quarter.
Edible oils and plantation at records; staples drag on divisional EBITDA
- Edible oils revenue Rs.8,505 Cr (segment best) in Q1 FY 2026-2027, with EBITDA margin of 5.2% — above the historical 2-4% band.
- Oil palm plantation revenue Rs.740 Cr (record, +25% YoY) in Q1 FY 2026-2027; management cited support from "government's National Mission on Edible Oils – Oil Palm".
- Biscuits revenue Rs.560 Cr (+27% YoY) in Q1 FY 2026-2027, with margin surging to 15.35% from 9.35% in Q1 FY 2025-2026; Good Biscuit brand annual run-rate ~Rs.1,300 Cr.
- Textured soy revenue Rs.160 Cr (+14% YoY, +50% QoQ, margin >18%) in Q1 FY 2026-2027; snacks business (incl. Good Biscuit) EBITDA margin >15%.
- Home & personal care revenue Rs.629 Cr in Q1 FY 2026-2027, comprising dental care Rs.325 Cr and skin care Rs.165 Cr.
- TSP segment revenue Rs.150 Cr with 18%+ EBITDA margin in Q1 FY 2026-2027; management reiterated full-year margin guidance of 15-18%.
- Divisional EBITDA split — Ethnic foods Rs.9 Cr, HPC Rs.122 Cr, Staples negative Rs.59 Cr in Q1 FY 2026-2027, the latter due to inventory markdowns on pulses and input inflation.
FY 2026-2027 targets reaffirmed; e-commerce and high-margin categories in focus
- FY 2026-2027 revenue guidance by vertical — management guided 8-10% growth for foods, ~15% for beauty & personal care, and 2-4% for edible oil; FMCG vertical EBITDA growth of 12-15%.
- FMCG segment target ~Rs.12,500 Cr in FY 2026-2027 (from ~Rs.11,000 Cr in FY 2025-2026), implying 10-12% growth including the HFC business.
- E-commerce / modern trade / quick commerce share reached ~15% in Q1 FY 2026-2027 (up from 12% over 15 months); management targets 20% within 18 months, by ~Q3 FY 2027-2028, with current YoY growth of ~25% on these channels.
- Product launch success rate of ~60-66% in Q1 FY 2026-2027, with 30-35% of launches underperforming and then tweaked; NPD pipeline strong in HPC (dental, skin) and biscuits over coming quarters.
- HPC business acquisition (Patanjali Ayurved) — slump sale for Rs.1,100 Cr in November 2024; the business generated ~Rs.600 Cr EBITDA in FY 2025-2026, implying <18-19 months multiple, which management stated has already been recovered.
- Staples revenue grew 30% sequentially (Q4 FY 2025-2026 to Q1 FY 2026-2027), an increase of ~Rs.260 Cr, aided by unique categories (Kesar, Rice) and new variants in lentils, pulses, and Besan.
Structural margin levers targeted; Rs.2,500 Cr annualized EBITDA in sight
- Edible oil EBITDA margin improvement to 5.2% in Q1 FY 2026-2027; management targets structural lift from the historical 2-4% range to 5%+, driven by scale and plantation integration.
- Annualized EBITDA target of ~Rs.2,500 Cr over the next 18 months (by approximately FY 2027-2028), supported by three levers: oil palm plantation growth >15% in FY 2026-2027, high-margin category expansion (HPC, Nutrela, biscuits), and edible oil margin improvement.
- Key cost headwinds — commodity price inflation, delayed monsoon, Red Sea conflict, Middle East geopolitical tensions affecting ghee exports, and higher packaging, freight, and logistics costs in Q1 FY 2026-2027.
- Food segment blip in Q1 FY 2026-2027 from inventory markdowns on pulses and higher input inflation, particularly in staples and ethnic foods; management expects to tide over the challenge.
- Selective price increases and small pack size introductions implemented to offset input cost pressures; oilseed acreage gap narrowed to 1.9% vs last year.
- Near-term risk — the staples division posted negative Rs.59 Cr EBITDA in Q1 FY 2026-2027; management noted staples are lower-margin but important for kitchen presence and reach.
Cautious on staples amid El Niño and rural demand; competitive tailwinds in dishwash
- Management cautious on staples outlook in FY 2026-2027 citing potential El Niño impact on agri output, food inflation, rural demand pressure, and possible government price controls on commodities.
- Dishwash category competition easing — management noted a large MNC competitor has exited or reduced presence in liquid dishwash, an expanding market; no plan to exit the category given strong performance.
- Nutraceutical portfolio turned positive after restructuring; management declined comment on the Bain Capital / Vitabiotics transaction, offering only a general view of the segment as fast-growing globally and in India.
- Arshav Advisory matter — management noted it is sub judice and agreed to discuss separately outside the call.
- Oilseed acreage gap narrowed to 1.9% vs last year, and government grain inventories remain healthy — partial offsets to supply concerns; management also highlighted government support via the National Mission on Edible Oils.
- All three acquisitions (biscuits, foods, and HPC) were conducted on a slump sale basis with no valuation methodology; details previously disclosed to stock exchanges and approved by shareholders.
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now